Safety advantage: Unlike HGH, AOD-9604 does not significantly impact IGF-1, insulin sensitivity, or blood sugar regulation Therapeutic potential: Initially investigated as an anti-obesity drug, it has since gained attention in the wellness and peptide therapy communities for weight loss and metabolic health
Some conditions like autoimmune thyroid disease, surgical gland removal, or advanced ovarian failure may limit how far levels normalize, but symptom relief is still often significant
We provide complete support including diet counselling, lifestyle modification guidance, and continuous monitoring for optimal results
In addition, GLP-1R overexpression results in improved cognitive function in mice and GLP-1R knockout severely impairs cognitive ability (117, 118)